LEVERAGE LONG - NOVARTIS N Share Price

Certificat

NO6LSG

DE000SB37GU2

Real-time Bid/Ask 11:03:57 23/05/2024 BST
30.76 CHF / 30.88 CHF +0.26% Intraday chart for LEVERAGE LONG - NOVARTIS N
Current month+28.03%
1 month+46.52%
Date Price Change
22/05/24 30.74 -2.57%
21/05/24 31.55 +2.70%
17/05/24 30.72 +4.99%
16/05/24 29.26 -6.55%
15/05/24 31.31 -0.41%

Delayed Quote Swiss Exchange

Last update May 22, 2024 at 04:20 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer Société Générale Société Générale
NO6LSG
ISINDE000SB37GU2
Date issued 07/08/2020
Maturity Unlimited
Parity 1 : 1
Emission price- CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 38.49 CHF
Lowest since issue 10.7 CHF
Spread 0.12 CHF
Spread %0.39%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
101.9 USD
Average target price
108.1 USD
Spread / Average Target
+6.08%
Consensus
  1. Stock Market
  2. Certificates
  3. NO6LSG Certificat